See the DrugPatentWatch profile for Methergine
Methergine and Hemabate are both medications used to control postpartum bleeding, but they have distinct contraindications.
What is Methergine prescribed for?
Methergine (methylergonovine) is used to prevent or control excessive bleeding after childbirth. It works by causing the muscles of the uterus to contract, which helps to compress blood vessels and reduce bleeding [1].
When should Methergine not be used?
Methergine is contraindicated in pregnant women, women in early labor, and those with hypersensitivity to the drug. It should also not be used for the induction or augmentation of labor. Furthermore, Methergine is not recommended for women with serious cardiovascular disease, peripheral vascular disease, or those with active liver or kidney disease [1]. Its use is also cautioned in cases of sepsis and in women over 35 who are heavy smokers [1].
What is Hemabate used for?
Hemabate (carboprost tromethamine) is another medication used to manage postpartum hemorrhage that has not responded to conventional treatments. It is a synthetic prostaglandin that causes uterine contractions to control bleeding [2].
What are the reasons to avoid Hemabate?
Hemabate is contraindicated in patients with hypersensitivity to carboprost tromethamine. It should not be used in women with pelvic inflammatory disease or active infections of the uterus. Caution is advised in patients with asthma, as prostaglandins can cause bronchoconstriction [2].
How do the uses of Methergine and Hemabate differ?
While both drugs treat postpartum hemorrhage, Methergine is often a first-line treatment for routine prevention of bleeding after delivery of the placenta. Hemabate is typically reserved for more severe or refractory cases of postpartum hemorrhage that do not respond to other interventions like oxytocin or Methergine [1][2].
Are there specific patient groups for whom these medications are not advised?
Individuals with significant cardiovascular issues or vascular disease should not use Methergine. Hemabate requires caution in patients with asthma due to potential respiratory side effects. Both medications can have systemic effects, and their use must be carefully considered by a healthcare professional based on the individual patient's medical history [1][2].
Sources:
[1] https://www.drugpatentwatch.com/drug/methylergonovine
[2] https://www.drugpatentwatch.com/drug/carboprost-tromethamine